A host of stocks are likely to remain in focus on Monday, July 22, driven by fresh corporate developments, Q1 earnings announcements, and new brokerage commentary. Here are the key names to track:
Positive developments
-
UltraTech stock: The company has guided for 10% year-on-year volume growth in FY26, supported by strong demand from the infrastructure and housing segments.
– Morgan Stanley has maintained an Overweight rating with a target price of ₹14,000, while Motilal Oswal has retained its Buy rating and raised the target price to ₹14,600. -
Titan share: Titan has acquired a 67% stake in Damas Jewellery at an enterprise value of ₹2,439 crore. The deal is expected to strengthen its footprint across GCC markets beyond the Indian diaspora.
– CLSA has maintained an Outperform rating with a target price of ₹4,326, and Morgan Stanley has also maintained an Overweight rating with a target price of ₹3,876. -
PNB Housing share: The company reported a 17% year-on-year growth in both net interest income and pre-provision operating profit. Disbursements also rose 14% YoY.
– Morgan Stanley has maintained an Overweight rating with a target price of ₹1,350. -
Sagar Cements stock: The company returned to profitability after four consecutive quarters of posting losses, supported by improved operational performance.
-
Bansal Wire share: The company reported a 15% increase in revenue and a 17% year-on-year rise in EBITDA for the first quarter.
-
Choice International stock: The firm posted a 50% jump in profit, while client assets under its stockbroking business grew 16% year-on-year.
-
Parag Milk share: The company registered a 12% increase in value sales and 5% volume growth, although margins declined by 40 basis points year-on-year.
-
Dr Reddy’s Laboratories stock: The USFDA has issued a Voluntary Action Indicated (VAI) classification for the company’s API manufacturing unit in New York.
-
BL Kashyap share: The company has secured a project worth ₹910 crore from real estate player BPTP.
-
Afcons Infrastructure stock: The company emerged as the lowest bidder (L1) for a railway project in Croatia worth ₹6,800 crore.
-
AGI Greenpac stock: The company’s revenue rose 21% year-on-year while EBITDA increased 20% during the first quarter.
Negative developments
-
Bajaj Finance share: Anup Saha, who was appointed MD in April 2025, has resigned. Rajeev Jain, the long-standing leader, has been re-designated as Vice Chairman and MD until March 2028.
– Jefferies has retained its Buy rating with a target price of ₹1,044, while Morgan Stanley has maintained an Overweight rating with a target price of ₹1,050. -
Havells share: The company reported a 6% year-on-year decline in revenue for Q1FY26, dragged by weak performance in the Lloyd and ECD segments.
– Jefferies has maintained a Hold rating and cut the target price to ₹1,635.
– Motilal Oswal has retained its Neutral rating with a target price of ₹1,680.
– CLSA has maintained an Outperform rating with a target price of ₹1,915.
– Morgan Stanley has maintained an Overweight rating with a target price of ₹1,884.
– Nuvama has retained its Buy rating, revising the target price to ₹1,820. -
360 ONE WAM share: BC Asia Investments plans to sell a 3.7% stake in the company through a block deal at a floor price which is 5% below the current market price.
-
CIE Automotive stock: While the company’s revenue rose 4% year-on-year, its margins declined by 200 basis points YoY and 120 basis points sequentially.
-
DCM Shriram stock: The company posted a 14% increase in revenue and a 70 basis point expansion in operating margins. However, analysts remain cautious on the caustic soda cycle despite volume growth of 20% YoY.
-
Dhanlaxmi Bank share: The bank’s gross non-performing assets (NPA) rose 10% sequentially, while net NPA increased by 18% quarter-on-quarter, indicating rising asset quality stress.
Disclaimer: The views expressed are those of the respective brokerages. This article does not constitute a recommendation to buy or sell any stock.
